Singlera Genomics Inc.
PrivateLast Round
Strategic
Jul 4, 2024
Total Funding Raised
$296.7M
Company Overview
Singlera Genomics Inc. is a biotechnology company that develops and commercializes non-invasive genetic tests for early cancer screening, diagnosis, and prognostic monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singlera Genomics Inc. Comparables
Compare Singlera Genomics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ClearNote Health | 85% | |
| Freenome | 83% | |
| ARNA Genomics | 83% |
Singlera Genomics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 4, 2024 | ||||
| Series B Extension | Jun 8, 2022 | ||||
| Series B | Dec 15, 2020 | ||||
| Series A Extension | Mar 27, 2018 | ||||
| Series A | Aug 22, 2016 | ||||
Angel | Jul 1, 2014 |
Singlera Genomics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 德同资本 | Series B |
| FutureX Capital | Series B |
| Wuxi Capital Group Co.,Ltd | Series B |
| Jingxu Venture Capital | Series B, Series A Extension |
| Huamei International Investment Group | Series B |
| Lilly Asia Ventures | Series A Extension, Series A |
| Jointown Pharmaceutical Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Partnering with the University of Pittsburgh for BT-Reveal test evaluation.
- Jun 8, 2022
$45M round with participation from Junci Investment and Brilliance Asset Management.
Singlera Genomics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Singlera Genomics Inc.'s valuation, stock price, and market status.
Is Singlera Genomics Inc. a public or private company?
Singlera Genomics Inc. is a private company.
What is the current stock price of Singlera Genomics Inc.?
Singlera Genomics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Singlera Genomics Inc. worth (valuation)?
Valuation information for Singlera Genomics Inc. is not publicly available.
Can I buy Singlera Genomics Inc. stock?
Singlera Genomics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Singlera Genomics Inc.'s last funding round?
Singlera Genomics Inc.'s most recent funding round was Strategic on July 4, 2024.
Who are the main investors in Singlera Genomics Inc.?
Key investors in Singlera Genomics Inc. include 德同资本, Lilly Asia Ventures, 松禾资本 (Green Pine Capital Partners).
Will Singlera Genomics Inc. IPO soon?
No public IPO plans have been announced for Singlera Genomics Inc..
How can I track Singlera Genomics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Singlera Genomics Inc.'s secondary market activity and sign up for updates.